A. Rascol And NotAssociation
List of bibliographic references
Number of relevant bibliographic references: 33.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 001557 | J. M. Senard [France] ; S. Rai [France] ; M. Lapeyre-Mestre [France] ; C. Brefel [France] ; O. Rascol [France] ; A. Rascol [France] ; J. L. Montastruc [France] | Prevalence of orthostatic hypotension in Parkinson's disease |
| 001733 | J.-L. Montastruc [France] ; N. Fabre [France] ; O. Blin [France] ; J.-M. Senard [France] ; O. Rascol [France] ; A. Rascol [France] | Does fluoxetine aggravate Parkinson's disease ? A pilot prospective study |
| 001743 | O. Rascol [France] ; U. Sabatini ; N. Fabre [France] ; J. M. Senard [France] ; M. Simonetta-Moreau [France] ; J. L. Montrastruc [France] ; M. Clanet [France] ; A. Rascol [France] | Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease |
| 001791 | O. Rascol [France] ; U. Sabatini [France] ; F. Chollet [France] ; N. Fabre [France] ; J. M. Senard [France] ; J. L. Montastruc [France] ; P. Calsis [France] ; J. P. Marc-Vergnes [France] ; A. Rascol [France] | Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa |
| 001792 | O. Rascol [France] ; N. Fabre [France] ; O. Blin ; J. Poulik [France] ; U. Sabatini [France] ; J.-M. Senard [France] ; M. Ane [France] ; J.-L. Montastruc [France] ; A. Rascol | Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease |
| 001816 | J. L. Montastruc [France] ; O. Rascol [France] ; J. M. Senard [France] ; A. Rascol | A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease : a five year follow up |
| 001846 | J. M. Senard [France] ; O. Rascol [France] ; B. Chamontin [France] ; A. Rascol [France] ; J.-L. Montastruc [France] | Enregistrement ambulatoire de la pression artérielle dans l'hypotension orthostatique de la maladie de Parkinson |
| 001855 | O. J. Rascol [France] ; M. Clanet [France] ; J. M. Senard [France] ; J. L. Montastruc [France] ; A. Rascol [France] | Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophy |
| 001874 | J. M. Senard [France] ; O. Rascol [France] ; A. Rascol ; J. L. Montastruc [France] | Lack of yohimbine effect on ambulatory blood pressure recording : a double-blind cross-over trial in Parkinsonians with orthostatic hypotension |
| 001875 | O. J. Rascol [France] ; U. Sabatini [France] ; F. Chollet [France] ; J. L. Montastruc [France] ; J. P. Marc-Vergnes [France] ; A. Rascol [France] | Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease : improvement by the dopamine agonist apomorphine |
| 001885 | J. M. Senard [France] ; O. Rascol [France] ; G. Durrieu [France] ; M. A. Tran [France] ; M. Berlan [France] ; A. Rascol ; J. L. Montastruc | Effects of Yohimbine on plasma catecholamine levels in orthostatic hypotension related to Pakinson disease or multiple system atrophy |
| 001948 | O. Rascol [France] ; U. Sabatini ; F. Chollet ; P. Celsis ; J.-L. Montastruc ; J.-P. Marc-Vergnes ; A. Rascol | Supplementary and primary sensory motor area activity in Parkinson's disease : regional cerebral blood flow changes during finger movements and effects of apomorphine |
| 001978 | A. Guillard [France] ; B. Dubois ; A. Rascol ; H. Allain | Passé, présent et futur du Parkinsonien |
| 001998 | J. L. Montrastuc [France] ; O. Rascol ; J. M. Senard ; V. Gualano ; H. Bagheri ; G. Houin ; A. Lees ; A. Rascol | Sublingual apomorphine in Parkinson's disease : a clinical and pharmacokinetic study |
| 001999 | U. Sabatini [France] ; O. Rascol ; P. Celsis ; G. Houin ; A. Rascol ; J. P. Marc-Vergnes ; J. L. Montastruc | Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms |
| 001A00 | O. Rascol [France] ; U. Sabatini ; SIMONETTA-MOREAU ; J. L. Montastruc ; A. Rascol ; M. Clanet | Square wave jerks in Parkinsonian syndromes |
| 001A17 | A. Agniel [France] ; P. Celsis ; G. Viallard ; J. L. Montastruc ; J. F. Demonet ; J. P. Marc-Vergnes ; A. Rascol | Cognition and cerebral blood flow in lateralised Parkinsonism : lack of functional lateral asymmetries |
| 001A43 | J. L. Montastruc ; O. Rascol ; A. Rascol | Comparison de la bromocriptine et de la levodopa dans le traitement de première intention de la maladie de Parkinson : résultats à 3 ans d'une étude prospective randomisée |
| 001A48 | G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J.-L. Montastruc ; P. Montastruc | β-Adrenergic sensitivity in Parkinson's disease : effect of levodopa treatment |
| 001A53 | U. Sabatini ; O. Rascol ; A. Rascol ; J.-L. Montastruc | Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patients |
| 001A91 | M. Berlan ; O. Rascol ; J. Belin ; J.-P. Moatti ; A. Rascol ; J.-L. Montastruc | α2-Adrenergic sensitivity in Parkinson's disease |
| 001B01 | O. Rascol ; M. Clanet ; J. L. Montastruc ; M. Simonetta ; M. J. Soulier-Esteve ; B. Doyon ; A. Rascol | Abnormal ocular movements in Parkinson's disease: evidence for involvement of dopaminergic systems |
| 001B17 | J.-P. Marc-Vergnes ; P. Celsis ; J. L. Montastruc ; J. F. Demonet ; A. Agniel ; O. Rascol ; G. Viallard ; B. Doyon ; A. Rascol | Hémodynamique cérébrale et pharmacologie clinique dans la maladie de Parkinson |
| 001B18 | P. Celsis ; O. Rascol ; J. F. Demonet ; A. Agniel ; J. L. Montastruc ; J. P. Marc-Vergnes ; A. Rascol | Effet de la bromocriptine sur le débit sanguin cérébral dans la maladies de Parkinson |
| 001B20 | J. L. Montastruc ; O. Rascol ; A. Rascol | Bromocriptine versus levodopa dans le traitement de première intention de la maladie de Parkinson. Premiers résultats à deux ans |
| 001B21 | O. Rascol ; J. L. Montastruc ; J. M. Senard ; J. F. Demonet ; M. Simonetta ; A. Rascol | Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial |
| 001B46 | M. Simonetta ; L. Schmitt ; J. L. Montastruc ; A. Rascol | Effets neuropsychiques secondaires de la bromocriptine dans la maladie de Parkinson |
| 001B58 | J. L. Montastruc ; P. Celsis ; A. Agniel ; J. F. Demonet ; B. Doyon ; M. Puel ; J. P. Marc-Vergnes ; A. Rascol | Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease: lack of correlation with clinical or neuropsychological improvements |
| 001B63 | J. L. Montastruc ; O. Rascol ; J. Belin ; M. Ane ; A. Rascol | Does papaverine interact with levodopa in Parkinson's disease? |
| 001B76 | J. F. Demonet ; M. Rostin ; J. M. Dueymes ; A. Ioualalen ; J. L. Montastruc ; A. Rascol | Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine |
| 001B78 | A. Rascol ; J. L. Montastruc ; O. Rascol ; J. M. Senard | Mesulergine (CU 32-085) in the treatment of Parkinson's disease |
| 001B85 | T. Venisse ; J. L. Montastruc ; A. Rascol | Pharmacologie clinique et traitement de la maladie de Parkinson |
| 001B97 | J. L. Montastruc ; A. Rascol | Traitement de la maladie de Parkinson par doses élevées de bromocriptine: interaction possible avec la josamycine |
| This area was generated with Dilib version V0.6.29. |  |